Arcturus Therapeutics Holdings, Inc. (ARCT)
7.68
+0.47
(+6.52%)
USD |
NASDAQ |
May 27, 16:00
7.68
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Cash from Investing (Quarterly) : 0.034M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Twist Bioscience Corp. | -12.71M |
| Denali Therapeutics, Inc. | 94.46M |
| Agenus, Inc. | 68.95M |
| Curis, Inc. | 0.00 |
| Plus Therapeutics, Inc. | -8.533M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.44M |
| Cash from Financing (Quarterly) | 0.016M |
| Free Cash Flow | -63.18M |
| Free Cash Flow Per Share (Quarterly) | -0.684 |
| Free Cash Flow to Equity (Quarterly) | -18.43M |
| Free Cash Flow to Firm (Quarterly) | -19.44M |
| Free Cash Flow Yield | -29.69% |